Transposon mediated multiplex sequencing

Details for Australian Patent Application No. 2001273185 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors August, Paul R.; Wiencis, Anna; Draper, Michael; Keagle, Pamela J.; Call, Katherine; Long, Henry

Agent Watermark

Pub. Number AU-B-2001273185

PCT Pub. Number WO02/04674

Priority 60/216,381 07.07.00 US

Filing date 5 July 2001

Wipo publication date 21 January 2002

Acceptance publication date 18 May 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

18 May 2006 Application Accepted

  Published as AU-B-2001273185

14 September 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001273186

2001273184